New test could match ovarian cancer patients to the right drug

NCT ID NCT03877796

Recruiting now Knowledge-focused Sponsor: Allarity Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 5 times

Summary

This study is testing a device called a Drug Response Predictor (DRP) that uses a sample of a patient's tumor to see if it will respond to certain cancer drugs. The trial involves 60 people with advanced ovarian cancer that has stopped responding to platinum chemotherapy. The goal is to see if the DRP can guide future treatment choices and also check if it correctly predicts past drug responses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Drug Response Predictor (DRP) assay
What this could lead to: If successful, this could help doctors choose the right cancer drug for each patient, improving treatment effectiveness.
What could go wrong: This is an early-stage study with only 60 participants, and the predictor may not accurately forecast drug response in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER

Contacts and locations

Locations

Beatson West of Scotland Cancer Centre
RECRUITING

Glasgow, Scotland, G12 0YN, United Kingdom
Emory Winship Cancer Institute
RECRUITING

Atlanta, Georgia, 30322, United States
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital
RECRUITING

London, United Kingdom
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
OU Health Stephenson Cancer Center
RECRUITING

Oklahoma City, Oklahoma, 73104, United States
Swedish Center for Research and Innovation
RECRUITING

Seattle, Washington, 98122, United States
The Blavatnik Family-Chelsea Medical Center at Mount Sinai
RECRUITING

New York, New York, 10011, United States
University Medical Center Cancer Center
RECRUITING

Lubbock, Texas, 79415, United States
University of New Mexico Comprehensive Cancer
RECRUITING

Albuquerque, New Mexico, 87131, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.